Cranial Technologies taps China's growing infant care market through CIIE debut

US-based medical device maker Cranial Technologies is making its debut at the China International Import Expo (CIIE) in Shanghai, aiming to tap into China's growing demand for advanced infant care solutions and position the country as one of its most important international markets.

"We are truly honored to participate in the CIIE for the first time — it's one of the world's most influential platforms for global trade and innovation," said Debbie James, chief executive officer of Cranial Technologies.

"CIIE provides a valuable platform for us to connect with potential partnerships that can help bring our world-class infant care solutions to more Chinese families. Our mission is closely aligned with the vision of Healthy China 2030, making this the ideal time to deepen our dialogue with this vital market."

The company has treated over 400,000 babies worldwide using its FDA-cleared DOC Band — the first cranial orthotic of its kind, designed to gently correct plagiocephaly, or flat head syndrome, during infancy. The product has received clearance from the National Medical Products Administration and will soon be available in the Chinese market.

Acknowledging China's open and high-standard business environment, James said it offers "tremendous opportunities" for international healthcare innovators like Cranial Technologies. At the CIIE, the company showcased the DOC Band, a custom-made orthotic helmet developed using proprietary 3D imaging technology and AI-driven design software.

"Each band is designed to address each baby's unique needs. Like snowflakes, no two are the same," she added.

Cranial Technologies began laying the groundwork for its entry into China in 2023. Its first clinic is located near Beijing Children's hospital, with strong partnerships formed in Shanghai and Wuhan, Hubei province.

The company's expansion has been bolstered by support from Eurazeo, a leading European private equity firm, and China Investment Corp (CIC), the country's sovereign wealth fund.

"We're entering China not just to offer a solution, but to share decades of clinical expertise and help more families give their babies a well-'rounded' start," James said.

wangzhuoqiong@chinadaily.com.cn